145 related articles for article (PubMed ID: 35854762)
21. [Conservative treatment of endometrial cancer as a way to preserve fertility. Five-year experience at Instituto Nacional de Perinatilogía Isidro Espinoza de los Reyes].
Arteaga Gómez AC; Castellanos Barroso G; Márquez Acosta G
Ginecol Obstet Mex; 2012 Jun; 80(6):394-9. PubMed ID: 22826967
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer.
Chae SH; Shim SH; Lee SJ; Lee JY; Kim SN; Kang SB
Int J Gynecol Cancer; 2019 Jan; 29(1):77-85. PubMed ID: 30640687
[TBL] [Abstract][Full Text] [Related]
23. Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia.
Wang Y; Zhou R; Wang H; Liu H; Wang J
Int J Gynecol Cancer; 2019 May; 29(4):699-704. PubMed ID: 30826750
[TBL] [Abstract][Full Text] [Related]
24. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
[TBL] [Abstract][Full Text] [Related]
25. Outcome of fertility-sparing treatment with medroxyprogesterone acetate for atypical hyperplasia and endometrial carcinoma in young Japanese women.
Kataoka H; Mori T; Yamamoto T; Sawada M; Kuroboshi H; Tatsumi H; Iwasaku K; Kitawaki J
Eur J Gynaecol Oncol; 2014; 35(1):11-5. PubMed ID: 24654454
[TBL] [Abstract][Full Text] [Related]
26. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications.
Sivalingam VN; Myers J; Nicholas S; Balen AH; Crosbie EJ
Hum Reprod Update; 2014; 20(6):853-68. PubMed ID: 25013215
[TBL] [Abstract][Full Text] [Related]
27. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
28. Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate.
Erdenebaatar C; Yamaguchi M; Saito F; Monsur M; Honda R; Tashiro H; Ohba T; Katabuchi H
Int J Gynecol Cancer; 2018 Mar; 28(3):539-544. PubMed ID: 29369118
[TBL] [Abstract][Full Text] [Related]
29. Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate.
Niwa K; Yokoyama Y; Tanaka T; Murase T; Morishita S; Itoh M; Itoh N; Shimokawa K; Tamaya T
Arch Gynecol Obstet; 1994; 255(2):91-4. PubMed ID: 8092891
[TBL] [Abstract][Full Text] [Related]
30. Treatment with medroxyprogesterone acetate plus levonorgestrel-releasing intrauterine system for early-stage endometrial cancer in young women: single-arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2009).
Kim MK; Seong SJ; Lee TS; Kim JW; Nam BH; Hong SR; Suh KS
Jpn J Clin Oncol; 2012 Dec; 42(12):1215-8. PubMed ID: 23071290
[TBL] [Abstract][Full Text] [Related]
31. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
Niu YJ; Shi HR; Xie Y
Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
[TBL] [Abstract][Full Text] [Related]
32. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations.
Imai M; Jobo T; Sato R; Kawaguchi M; Kuramoto H
Eur J Gynaecol Oncol; 2001; 22(3):217-20. PubMed ID: 11501776
[TBL] [Abstract][Full Text] [Related]
33. The evolving role of targeted metformin administration for the prevention and treatment of endometrial cancer: A systematic review and meta-analysis of randomized controlled trials.
Prodromidou A; Lekka S; Fotiou A; Psomiadou V; Iavazzo C
J Gynecol Obstet Hum Reprod; 2021 Nov; 50(9):102164. PubMed ID: 33992830
[TBL] [Abstract][Full Text] [Related]
34. Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer.
Kim MK; Seong SJ; Kim YS; Song T; Kim ML; Yoon BS; Jun HS; Lee YH
Am J Obstet Gynecol; 2013 Oct; 209(4):358.e1-4. PubMed ID: 23791687
[TBL] [Abstract][Full Text] [Related]
35. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group.
Thigpen JT; Brady MF; Alvarez RD; Adelson MD; Homesley HD; Manetta A; Soper JT; Given FT
J Clin Oncol; 1999 Jun; 17(6):1736-44. PubMed ID: 10561210
[TBL] [Abstract][Full Text] [Related]
36. Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia.
Campo G; Rebecchi A; Vanni VS; Pagliardini L; Patruno C; Papaleo E; Candiani M; Giardina P
Reprod Biomed Online; 2021 Nov; 43(5):864-870. PubMed ID: 34629315
[TBL] [Abstract][Full Text] [Related]
37. LNG-IUS combined with progesterone ameliorates endometrial thickness and pregnancy outcomes of patients with early-stage endometrial cancer or atypical hyperplasia.
Fang F; Xu H; Wu L; Hu L; Liu Y; Li Y; Zhang C
Am J Transl Res; 2021; 13(5):5412-5419. PubMed ID: 34150138
[TBL] [Abstract][Full Text] [Related]
38. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
[TBL] [Abstract][Full Text] [Related]
39. Fertility-sparing therapy for young women with endometrial cancer.
Frumovitz M; Gershenson DM
Expert Rev Anticancer Ther; 2006 Jan; 6(1):27-32. PubMed ID: 16375641
[TBL] [Abstract][Full Text] [Related]
40. Fertility-sparing management for endometrial cancer: review of the literature.
Garzon S; Uccella S; Zorzato PC; Bosco M; Franchi MP; Student V; Mariani A
Minerva Med; 2021 Feb; 112(1):55-69. PubMed ID: 33205638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
